Rapt Therapeutics (United States)
- World rank, 2022–2025
- #13,367 of 28,054 · #17,379 all time
- Rank in United States
- #1,861 of 4,192
- Research works
- 171 ▲ 413% vs 2013–17
- Citations
- 6.1k 35.7 per fractional work
- Top-10% rate
- 15.9% record average 16.5%
- Open access
- 48% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.2×. Every wedge is a field page.
- Immunology and Microbiology 11.2×
- Biochemistry, Genetics and Molecular Biology 4.6×
- Medicine 2.6×
- Pharmacology, Toxicology and Pharmaceutics 1.9×
- Neuroscience 1.8×
- Chemistry 1.1×
- Psychology 0.8×
- Mathematics 0.3×
- Materials Science 0.2×
- Nursing 0.2×
- Engineering 0.2×
- Environmental Science 0.1×
- Computer Science 0.1×
- Health Professions 0.1×
- Agricultural and Biological Sciences 0.1×
- Economics, Econometrics and Finance 0.0×
- Social Sciences 0.0×
Which keywords describe research at Rapt Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Lymphoma, Leukemia, CAR T Cells, Chimeric Antigen Receptor and Inflammation.
- Immunosuppression
- NK Cell Recognition
- Therapeutic Targets
- Genome Engineering
- Metastasis
- Vaccine Adjuvants
- Genetic Mutations
- Antigen Presentation
- Targeted Therapy
- Immune Checkpoint Blockade
- Immunity
- PET Imaging
- Angiogenesis
- Therapeutic Antibodies
- Glycosylation
- Cancer
- Chimeric Antigen Receptor
- Lymphoma
- Tumor Regression
- Immunotherapy
- Cancer Immunotherapy
- Inflammation
- Leukemia
- CAR T Cells
- Tumor Microenvironment
- Monoclonal Antibodies
- Fc Receptors
- Innate Immunity
- Dendritic Cells
- Cancer Therapy
- Atherosclerosis
- PD-1 and PD-L1
- Neurodegeneration
- Clinical Trials
- Tumor Antigen
- Drug Discovery
- Cytokines
- RNA-Guided
- Medicinal Chemistry
- Natural Killer Cells
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Immunotherapy8▲ 77×3 topics
- Immunotherapy8▲ 16×14 topics
- Inflammation7▲ 4.5×26 topics
- Tumor Regression6▲ 82×2 topics
- Leukemia6▲ 105×2 topics
- Lymphoma6▲ 55×3 topics
- CAR T Cells6▲ 115×1 topic
- Chimeric Antigen Receptor6▲ 115×1 topic
- Tumor Microenvironment5▲ 15×6 topics
- Cancer5▲ 5.0×24 topics
- Monoclonal Antibodies5▲ 72×2 topics
- Glycosylation4▲ 53×3 topics
- Fc Receptors4▲ 101×1 topic
- Therapeutic Antibodies4▲ 79×1 topic
- Innate Immunity4▲ 16×6 topics
- Angiogenesis4▲ 15×6 topics
- Dendritic Cells3▲ 46×2 topics
- PET Imaging3▲ 23×3 topics
- Cancer Therapy3▲ 6.5×5 topics
- Immunity2▲ 8.5×3 topics
- Atherosclerosis2▲ 11×7 topics
- Immune Checkpoint Blockade2▲ 29×1 topic
- PD-1 and PD-L12▲ 29×1 topic
- Targeted Therapy2▲ 15×3 topics
- Neurodegeneration2▲ 9.8×7 topics
- Antigen Presentation2▲ 31×2 topics
- Clinical Trials2▲ 4.2×5 topics
- Genetic Mutations2▲ 6.1×10 topics
- Tumor Antigen2▲ 44×1 topic
- Vaccine Adjuvants2▲ 44×1 topic
- Drug Discovery2▲ 11×5 topics
- Metastasis2▲ 7.5×3 topics
- Cytokines2▲ 8.3×4 topics
- Genome Engineering2▲ 36×1 topic
- RNA-Guided2▲ 36×1 topic
- Therapeutic Targets2▲ 15×4 topics
- Medicinal Chemistry2▲ 8.2×3 topics
- NK Cell Recognition2▲ 34×1 topic
- Natural Killer Cells2▲ 34×1 topic
- Immunosuppression2▲ 23×2 topics
Which research topics does Rapt Therapeutics (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 6 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 4 Immunotherapy and Immune Responses Immunology 2 works
- 5 CRISPR and Genetic Engineering Molecular Biology 2 works
- 6 Immune Cell Function and Interaction Immunology 2 works
- 7 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 8 Peptidase Inhibition and Analysis Oncology 1 works
- 9 S100 Proteins and Annexins Molecular Biology 1 works
- 10 Atherosclerosis and Cardiovascular Diseases Immunology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Rapt Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 413% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South San Francisco
- Sunesis (United States)
- Exelixis (United States)
- Kaiser Permanente South San Francisco Medical Center
- Cytokinetics (United States)
- Portola Pharmaceuticals (United States)
- NGM Biopharmaceuticals (United States)
- Atara Biotherapeutics (United States)
- Fluidigm (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.